Astrana Health Inc. (ASTH)
NASDAQ:ASTH
Want to see ASTH full AI Analyst Report?
Earnings Data
Report Date
Aug 12, 2026TBA (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.33Last Year’s EPS
0.19Same Quarter Last Year
Strong Buy
Based on 9 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented a strong operational and financial quarter with outsized revenue and EBITDA growth, meaningful free cash flow, accelerated deleveraging, confirmed platform‑driven operating leverage from AI, and on‑track integration of the Prospect acquisition. Management remains deliberately conservative in full‑year guidance due to enrollment and HQAF timing uncertainties and highlighted working capital effects from full‑risk transitions. Overall, the positives (robust growth, margin expansion levers, rapid deleveraging, and platform advantages) outweigh the manageable execution and macro/regulatory uncertainties called out by management.Company Guidance
Strong Top-Line and Profitability Growth
Q1 revenue of $965.1M, up 56% year‑over‑year; adjusted EBITDA $66.3M, up 82% YoY; non‑GAAP adjusted EPS $0.74, up 76% YoY; net income attributable to Astrana $14.4M.
Robust Free Cash Flow and Deleveraging
Free cash flow of $64.1M in the quarter; cash balance $478.4M and net debt $586.8M; pro forma net leverage ~2.3x (TTM) and ~2.2x at guidance midpoint — reached sub‑2.5x target within 3 quarters and expect to finish the year at or below 2.0x.
AI‑Enabled Platform Demonstrating Operational Leverage
G&A improved to 6.4% of revenue (70 basis point improvement YoY); providers using the platform achieved 24% higher gap closure and 30% higher annual wellness visit completion; ~500,000 automated member interactions per month; AI claims agents cut provider payment cycle times to less than half of manual processing.
Membership and Risk Progression
Serving ~1.55M members in value‑based care; ~80% of Care Partners revenue and ~40% of owned membership in full‑risk arrangements, with new full‑risk contracts performing in line with underwriting.
Prospect Transaction Integration and Synergies
Prospect integration on track: gross provider retention >99%; tracking toward the high end of the $12M–$15M annual synergy target; Prospect on an ~$80M adjusted EBITDA annualized run‑rate and currently tracking ahead of expectations.
Affirmed 2026 Financial Outlook
Reaffirmed full‑year 2026 guidance: revenue $3.8B–$4.1B, adjusted EBITDA $250M–$280M, free cash flow $105M–$132.5M. Q2 guidance: revenue $965M–$1.0B and adjusted EBITDA $65M–$70M.
Clinical and Medical Cost Performance
Quarterly medical cost trends slightly outperformed the company full‑year blended assumption of ~5.2%; strong performance across core Astrana and legacy Prospect populations; Southern Nevada reached run‑rate profitability in 2025 with a 20% YoY improvement in MLR.
Regulatory Positioning
Management views the 2027 Medicare Advantage final rate notice as a structural tailwind: Astrana expects limited impact from disallowed diagnosis sources and believes its conservative, longitudinal approach to risk adjustment positions it well under revised frameworks.
ASTH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ASTH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 07, 2026 | $36.08 | $39.30 | +8.92% |
Mar 04, 2026 | $24.51 | $25.59 | +4.41% |
Nov 06, 2025 | $33.36 | $25.54 | -23.46% |
Aug 07, 2025 | $21.46 | $28.08 | +30.85% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Astrana Health Inc. (ASTH) report earnings?
Astrana Health Inc. (ASTH) is schdueled to report earning on Aug 12, 2026, TBA (Confirmed).
What is Astrana Health Inc. (ASTH) earnings time?
Astrana Health Inc. (ASTH) earnings time is at Aug 12, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ASTH EPS forecast?
ASTH EPS forecast for the fiscal quarter 2026 (Q2) is 0.33.